Stock listing
OTC:ALUR Allurion Technologies, Inc. Stock
Follow Allurion Technologies, Inc. into a list and get an email when it puts out news.
Share price · OTC:ALUR
$0.0021 USD 0.0000 (0.0%)
Close on Nov 18, 2026
- Day range
- $0.0021 – $0.0021 USDNov 18, 2026
- Volume
- 463 sharesNov 18, 2026
- Market cap
- —Left out: price × shares is far from the company's reported size
- Traded on an average day
- $2,881 USDMedian day 736 shares · 9 days with no trades · last 3 months, Aug 18, 2026 – Nov 18, 2026
Daily closes
Last 3 months, Aug 18, 2026 – Nov 18, 2026 · OTC:ALUR · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.0021 | 0.0000 | 0.0% | $0.0021 | $0.0021 | $0.0021 | 463 | |
| $0.0021 | +0.0001 | +5.0% | $0.0007 | $0.0021 | $0.0007 | 418 | |
| $0.0020 | 0.0000 | 0.0% | $0.0020 | $0.0020 | $0.0020 | 1,305 | |
| $0.0020 | 0.0000 | 0.0% | $0.0020 | $0.0020 | $0.0020 | 199 | |
| $0.0020 | -0.0001 | -4.8% | $0.0020 | $0.0020 | $0.0020 | 307 | |
| $0.0021 | +0.0011 | +110.0% | $0.0020 | $0.0021 | $0.0020 | 726 | |
| $0.0010 | -0.0004 | -28.6% | $0.0010 | $0.0010 | $0.0010 | 294 | |
| $0.0014 | -0.0191 | -93.2% | $0.0009 | $0.0014 | $0.0009 | 1,815 | |
| $0.0205 | +0.0105 | +105.0% | $0.0100 | $0.0205 | $0.0100 | 746 | |
| $0.0100 | -0.0055 | -35.5% | $0.0100 | $0.0100 | $0.0100 | 302 | |
| $0.0155 | -0.4595 | -96.7% | $0.0155 | $0.0155 | $0.0155 | 403 | |
| $0.4750 | 0.0000 | 0.0% | $0.4750 | $0.4750 | $0.4750 | 0 | |
| $0.4750 | 0.0000 | 0.0% | $0.4750 | $0.4750 | $0.4750 | 0 | |
| $0.4750 | 0.0000 | 0.0% | $0.4750 | $0.4750 | $0.4750 | 0 | |
| $0.4750 | 0.0000 | 0.0% | $0.4750 | $0.4750 | $0.4750 | 0 | |
| $0.4750 | 0.0000 | 0.0% | $0.4750 | $0.4750 | $0.4750 | 0 | |
| $0.4750 | -0.1250 | -20.8% | $0.4750 | $0.4750 | $0.4750 | 200 | |
| $0.6000 | +0.0830 | +16.1% | $0.4000 | $0.6000 | $0.4000 | 11,800 | |
| $0.5170 | +0.0070 | +1.4% | $0.5170 | $0.5170 | $0.5170 | 1,700 | |
| $0.5100 | -0.0530 | -9.4% | $0.4000 | $0.5800 | $0.4000 | 8,000 | |
| $0.5630 | +0.1130 | +25.1% | $0.5630 | $0.5630 | $0.5630 | 300 | |
| $0.4500 | -0.0510 | -10.2% | $0.4590 | $0.4590 | $0.4000 | 6,000 | |
| $0.5010 | +0.0090 | +1.8% | $0.5800 | $0.5800 | $0.4340 | 11,600 | |
| $0.4920 | +0.0020 | +0.4% | $0.4920 | $0.4920 | $0.4920 | 200 | |
| $0.4900 | -0.1100 | -18.3% | $0.4900 | $0.4900 | $0.4900 | 300 | |
| $0.6000 | -0.1770 | -22.8% | $0.6240 | $0.6900 | $0.6000 | 6,100 | |
| $0.7770 | -0.2730 | -26.0% | $0.9520 | $0.9520 | $0.7330 | 10,200 | |
| $1.0500 | 0.0000 | 0.0% | $1.0500 | $1.0500 | $1.0500 | 0 | |
| $1.0500 | -0.0560 | -5.1% | $1.1420 | $1.1420 | $1.0500 | 500 | |
| $1.1060 | -0.0040 | -0.4% | $1.1300 | $1.1300 | $1.1060 | 300 | |
| $1.1100 | 0.0000 | 0.0% | $1.1100 | $1.1100 | $1.1100 | 0 | |
| $1.1100 | -0.0400 | -3.5% | $1.1100 | $1.1100 | $1.1100 | 4,800 | |
| $1.1500 | +0.1300 | +12.7% | $1.0500 | $1.1500 | $1.0500 | 400 | |
| $1.0200 | 0.0000 | 0.0% | $1.0200 | $1.0200 | $1.0200 | 0 | |
| $1.0200 | -0.0300 | -2.9% | $1.0700 | $1.0800 | $1.0200 | 1,600 | |
| $1.0500 | -0.1400 | -11.8% | $1.0300 | $1.0500 | $1.0100 | 6,300 | |
| $1.1900 | +0.0300 | +2.6% | $1.1500 | $1.1900 | $1.1500 | 200 | |
| $1.1600 | -0.0860 | -6.9% | $1.2100 | $1.2100 | $1.1600 | 1,400 | |
| $1.2460 | +0.0370 | +3.1% | $1.2460 | $1.2460 | $1.2460 | 300 | |
| $1.2090 | 0.0000 | 0.0% | $1.2090 | $1.2090 | $1.2090 | 0 | |
| $1.2090 | +0.0390 | +3.3% | $1.1300 | $1.2090 | $1.1300 | 1,100 | |
| $1.1700 | -0.0450 | -3.7% | $1.2100 | $1.2100 | $1.1400 | 4,800 | |
| $1.2150 | -0.0650 | -5.1% | $1.2000 | $1.2600 | $1.2000 | 1,600 | |
| $1.2800 | +0.1600 | +14.3% | $1.1200 | $1.3710 | $1.1200 | 14,000 | |
| $1.1200 | +0.0200 | +1.8% | $1.0920 | $1.1200 | $1.0920 | 1,800 | |
| $1.1000 | -0.0700 | -6.0% | $1.2000 | $1.2000 | $1.1000 | 500 | |
| $1.1700 | -0.3300 | -22.0% | $1.1800 | $1.1800 | $1.1700 | 400 | |
| $1.5000 | +0.1200 | +8.7% | $1.3800 | $1.5500 | $1.3800 | 2,300 | |
| $1.3800 | -0.0700 | -4.8% | $1.4500 | $1.4500 | $1.3800 | 500 | |
| $1.4500 | +0.0900 | +6.6% | $1.6890 | $1.6950 | $1.4500 | 1,900 | |
| $1.3600 | -0.3900 | -22.3% | $1.7500 | $1.8320 | $1.3600 | 5,200 | |
| $1.7500 | -0.0200 | -1.1% | $1.7500 | $1.7500 | $1.7500 | 1,100 | |
| $1.7700 | -0.2400 | -11.9% | $1.7000 | $1.9000 | $1.7000 | 1,500 | |
| $2.0100 | -0.0550 | -2.7% | $2.0500 | $2.0500 | $1.7000 | 1,600 | |
| $2.0650 | +0.1150 | +5.9% | $2.1900 | $2.1900 | $2.0200 | 1,500 | |
| $1.9500 | -0.3400 | -14.8% | $2.2000 | $2.2000 | $1.8000 | 3,200 | |
| $2.2900 | -0.4700 | -17.0% | $2.5600 | $2.7000 | $1.9900 | 14,000 | |
| $2.7600 | -0.6420 | -18.9% | $3.3900 | $3.3900 | $2.5100 | 8,800 |
Splits
2 splits since 2025 · OTC:ALUR · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-15 | Consolidation | |
| 1-for-25 | Consolidation |
- Ticker
- OTC:ALUR
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- OTC
- Currency
- USD
What changed lately
Latest earnings call · Nov 13, 2026
Allurion Technologies (OTC:ALUR) Q3 2026 Earnings Call
Replay and transcript
Allurion Technologies, Inc. on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- Calls
- 8 calls with a replay · 8 with a transcript · latest Nov 13, 2026
- Decks
- 3 decks · latest Jun 26, 2024
Valuation
Statements: 4 quarters to Mar 31, 2026 · price Nov 18, 2026
- Enterprise value
- No market cap
- P/E
- No market cap
- EV/sales
- No market cap
- EV/EBITDA
- No market cap
- Price/book
- No market cap
- Gross margin
- 52.7%
- Operating margin
- −211.2%
- Net margin
- −264.7%
- Debt to equity
- Negative equity
- Beta vs S&P 500
- -0.42
Forecasts
Analysts' consensus from EODHD, read Nov 18, 2026. Not 6ix's view and not investment advice.
- Price target
- 82.50 USD · Analysts' mean
- EPS, year to Dec 2026
- -20.25 · 1 analyst
Team and board
Officers
| Officer | Role |
|---|---|
| Shantanu Gaur | Chief Executive Officer and Co-Founder |
| Ojas A. Buch | Chief Operating Officer |
| Brendan Gibbons | Chief Legal Officer |
| Ram Chuttani M.D | Chief Medical Officer and Founding Partner |
Board
| Director | Role |
|---|---|
| Douglas Hudson | Director |
| Keith Johns | Director |
| Krishna K. Gupta | Director |
| Michael Davin | Director |
| Nicholas Lewin | Director |
| Omar Ishrak | Board Member |
| R. Jason Richey | Director |
Events
Calls
| Call | When | Status |
|---|---|---|
| Allurion Technologies (OTC:ALUR) Q3 2026 Earnings Call | Fri, Nov 13, 2026 · 1:00 AM ET | Replay |
| Allurion Technologies (OTC:ALUR) Q3 2025 Earnings Call | Thu, Nov 13, 2025 · 1:30 AM ET | Replay |
| Allurion Technologies (OTC:ALUR) Q2 2025 Earnings Call | Wed, Aug 13, 2025 · 8:30 AM ET | Replay |
| Allurion Technologies (OTC:ALUR) Q1 2025 Earnings Call | Wed, May 14, 2025 · 8:30 AM ET | Replay |
| Allurion Technologies (OTC:ALUR) Q4 2024 Earnings Call | Wed, Mar 26, 2025 · 8:30 AM ET | Replay |
| Allurion Technologies (OTC:ALUR) Q3 2024 Earnings Call | Wed, Nov 13, 2024 · 8:30 AM ET | Replay |
| Allurion Technologies (OTC:ALUR) Q1 2024 Earnings Call | Tue, May 14, 2024 · 8:30 AM ET | Replay |
| Allurion Technologies (OTC:ALUR) Q4 2023 Earnings Call | Thu, Mar 21, 2024 · 8:00 AM ET | Replay |
Results days
| Quarter | Results |
|---|---|
| Q1 2026 | May 20, 2026 |
| Q4 2025 | Mar 19, 2026 |
| Q3 2025 | Nov 12, 2025 |
| Q2 2025 | Aug 19, 2025 |
| Q1 2025 | May 15, 2025 |
| Q4 2024 | Mar 27, 2025 |
| Q3 2024 | Nov 13, 2024 · Before open |
| Q2 2024 | Aug 13, 2024 · Before open |
| Q1 2024 | May 14, 2024 · Before open |
| Q4 2023 | Mar 26, 2024 · After close |
All 19 quarters
| Quarter | Results |
|---|---|
| Q3 2023 | Nov 29, 2023 |
| Q1 2023 | Apr 4, 2023 |
| Q3 2022 | Nov 21, 2022 |
| Q2 2022 | Aug 15, 2022 |
| Q1 2022 | May 13, 2022 |
| Q4 2021 | Mar 31, 2022 |
| Q3 2021 | Nov 19, 2021 |
| Q2 2021 | Aug 16, 2021 |
| Quarter to Mar 31, 2021 | May 24, 2021 |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| IPO Roadshow (June 2024) | IPO roadshow | 24 slides | Jun 26, 2024 |
| SPAC Merger (June 2023) | SPAC merger | 25 slides | Jun 9, 2023 |
| SPAC Merger (February 2023) | SPAC merger | 47 slides | Feb 10, 2023 |
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 15.2M | 32.1M | 53.5M | 64.2M | 38.2M | |
| Cost of revenue | 5.66M | 10.6M | 12.0M | 13.5M | 9.05M | |
| Gross profit | 9.57M | 21.5M | 41.5M | 50.7M | 29.2M | |
| Research and development | 7.57M | 17.4M | 27.7M | 17.0M | 5.73M | |
| Selling, general and administrative | 21.4M | 28.4M | 46.0M | 15.4M | 8.82M | |
| Operating income | -30.2M | -50.2M | -79.1M | -32.0M | -12.5M | -5.17K |
| Depreciation and amortization | 983.0K | 997.0K | 746.0K | 895.0K | 707.0K | 21 |
| EBITDA | -29.2M | -49.2M | -78.3M | -31.1M | -11.8M | -5.15K |
| Interest expense | 0 | 2.26M | 10.6M | 4.43M | 3.67M | |
| Income before tax | -28.7M | -6.48M | -82.6M | -37.6M | -12.4M | -5.17K |
| Income tax | 74.0K | 718.0K | 264.0K | 143.0K | 3.11M | -206.3K |
| Net income | -28.8M | -7.20M | -82.8M | -37.7M | -12.4M | -5.17K |
| Earnings per share, basic | -3.81 | -3.20 | -59.38 | -37.75 | -43.08 | -0.02 |
| Earnings per share, diluted | -3.81 | -3.20 | -59.38 | -37.75 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cash and equivalents | 5.41M | 15.4M | 38.0M | 7.68M | 25.8M | 47.1K |
| Receivables | 3.95M | 7.13M | 18.2M | 29.3M | 6.83M | |
| Inventory | 2.67M | 3.40M | 6.17M | 3.87M | 2.71M | |
| Current assets | 12.8M | 27.2M | 64.8M | 43.4M | 37.3M | 47.1K |
| Property, plant and equipment | 1.37M | 2.47M | 3.38M | 2.38M | ||
| Total assets | 15.8M | 32.8M | 71.7M | 51.4M | 39.4M | 330.0K |
| Accounts payable | 3.57M | 6.57M | 10.4M | 5.81M | 1.62M | |
| Current liabilities | 38.4M | 18.9M | 65.4M | 75.9M | 31.6M | 310.1K |
| Long-term debt | 0 | 35.7M | 3.10M | 2.00M | ||
| Total debt | 0 | 71.4M | 38.6M | 56.5M | 26.1M | 170.0K |
| Total liabilities | 93.0M | 110.8M | 143.0M | 83.7M | 73.6M | 310.1K |
| Shareholders' equity | -77.2M | -78.0M | -71.3M | -32.3M | -34.3M | 19.8K |
| Shares outstanding | 12.3M | 2.71M | 1.91M | 1.08M | 287.5K | 287.5K |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cash from operations | -28.9M | -42.3M | -64.0M | -47.0M | -14.3M | -35 |
| Capital spending | 0 | -611.0K | -1.61M | -1.55M | -912.0K | -5 |
| Free cash flow | -28.9M | -42.9M | -65.6M | -48.5M | -15.2M | -40 |
| Cash from investing | -611.0K | -1.61M | -1.55M | -912.0K | ||
| Cash from financing | 19.0M | 20.2M | 96.0M | 30.5M | 28.9M | 47.1K |
| Dividends paid | -132.0K | |||||
| Share buybacks | -776.5M | |||||
| Change in cash | -9.98M | -22.7M | 30.4M | -18.0M | 13.7M | 47.1K |
Cap table
Built by 6ix from Allurion Technologies, Inc.’s releases
- Common shares
- 607,651
- Fully diluted
- 607,651
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 607,651 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 607,651 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| S. Omar Ishrak Other companies: Amgen Inc. (Director · Since at least Jul 29, 2021); Compute Health Acquisition Corp (Director · Feb 4, 2021 – Aug 1, 2023 · Past); Intel Corporation (Director · Mar 21, 2017 – Mar 28, 2025 · Past); Medtronic plc. (Executive Chairman, Director · Jun 13, 2011 – Oct 15, 2020 · Past) | Board Member · Since at least Aug 1, 2023 |
| Nicholas Lewin Other companies: Establishment Labs Holdings Inc. (Director · Since at least Jul 18, 2018); Cutera Inc (Director · May 19, 2023 – Oct 24, 2024 · Past) | Director · Since at least Aug 1, 2023 |
| Brendan Gibbons Other companies: Acushnet Holdings Corp. (See Remarks · Dec 18, 2020 – Jun 18, 2021 · Past) | Chief Legal Officer · Since at least Jan 29, 2024 |
| Michael Davin Other companies: Cynosure Inc (Chairman, President and CEO, Director · Dec 31, 2015 – Mar 22, 2017 · Past) | Director · Since at least Aug 1, 2023 |
| Roderick Wong Other companies: Rocket Pharmaceuticals, Inc. (Director · Since at least Jun 13, 2024) | Director · Since at least Apr 16, 2025 |
| Benoit Chardon | Chief Commercial Officer · Aug 1, 2023 – Dec 12, 2023 · Past |
| Christopher J Geberth | Chief Financial Officer · Aug 1, 2023 – Aug 1, 2023 · Past |
| Douglas Hudson | Director · Since at least Nov 5, 2026 |
| Keith Johns | Director · Since at least Nov 5, 2026 |
| Krishna K. Gupta | Director · Since at least Nov 5, 2026 |
All 14 people
| Person | Seat |
|---|---|
| Ojas A. Buch | Chief Operating Officer · Since at least Nov 5, 2026 |
| Ram Chuttani M.D | Chief Medical Officer and Founding Partner · Since at least Aug 1, 2023 |
| R. Jason Richey | Director · Since at least Nov 5, 2026 |
| Shantanu Gaur | Chief Executive Officer and Co-Founder · Since at least Aug 1, 2023 |
Log in to ask 6ix AI your own questions about Allurion Technologies, Inc.